Kevin Loewke, PhD, is the co-founder and CEO of Cellogy, a startup focused on stem-cell based modeling of human disease through quantitative imaging and machine learning. Prior to Cellogy, he was co-founder of Auxogyn, a medical device startup in the field of reproductive health. He created and led development of Auxogyn’s flagship product, Eeva, which uses time-lapse imaging and computer vision to predict the viability of pre-implantation human embryos during IVF procedures. His post-doctoral research in embryo development was conducted at the Stanford Institute for Stem Cell Biology, profiled as a top 10 medical breakthrough by Time Magazine, and published in Nature Biotechnology and Nature Communications. He received his PhD from Stanford with a focus on biomedical image analysis.